본문 바로가기
KERD
논문KCI 등재

자궁 내 염증이 동반된 임신에서 멜라토닌의 태아 보호 효과에 대한 고찰

A Review on the Effects of Melatonin on Fetal Protection during Pregnancy with Intrauterine Inflammation

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Intrauterine inflammation is defined as the inflammation of the chorion, amnion, and placenta. Untreated inflammation increases the risk of fetal inflammatory response syndrome, which may result in multiorgan diseases involving the brain, cardiovascular system, lung, eye, and intestine. Therefore, controlling inflammation is critical in pregnant women to reduce the risk of diseases. However, there are no safe and effective anti-inflammatory drugs for administration during pregnancy. Although the primary function of melatonin is to control circadian rhythms, it has protective effects against cellular insults occurring from hypoxia, oxidative stress, and inflammation. While animal studies support the effective and safe role of melatonin in improving pregnancy-related morbidities, it leaves plenty of opportunities for clinical studies investigating its anti-inflammatory, antioxidant, and protective effects against insults induced by intrauterine inflammation. Therefore, it will be worthwhile to investigate antenatal supplementation of melatonin in pregnant women with intrauterine inflammation to reduce the incidence of associated comorbidities.

Abstract

Intrauterine inflammation is defined as the inflammation of the chorion, amnion, and placenta. Untreated inflammation increases the risk of fetal inflammatory response syndrome, which may result in multiorgan diseases involving the brain, cardiovascular system, lung, eye, and intestine. Therefore, controlling inflammation is critical in pregnant women to reduce the risk of diseases. However, there are no safe and effective anti-inflammatory drugs for administration during pregnancy. Although the primary function of melatonin is to control circadian rhythms, it has protective effects against cellular insults occurring from hypoxia, oxidative stress, and inflammation. While animal studies support the effective and safe role of melatonin in improving pregnancy-related morbidities, it leaves plenty of opportunities for clinical studies investigating its anti-inflammatory, antioxidant, and protective effects against insults induced by intrauterine inflammation. Therefore, it will be worthwhile to investigate antenatal supplementation of melatonin in pregnant women with intrauterine inflammation to reduce the incidence of associated comorbidities.

참고문헌 (83)

  1. Alghamdi BS, "The neuroprotective role of melatonin in neurological disorders", J Neurosci Res, 96, pp.1136~1149 (2018)
  2. Ambalavanan N, "Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants", Pediatrics, 123, pp.1132~1141 (2009)
  3. Balinotti JE, "Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy", Am J Respir Crit Care Med, 181, pp.1093~1097 (2010)
  4. Bell MJ, "Effects of intrauterine inflammation on developing rat brain", J Neurosci Res, 70, pp.570~579 (2002)
  5. Bosma KJ, "Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome", Drugs, 70, pp.1255~1282 (2010)
  6. Bourbon J, "Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia", Pediatr Res, 57, pp.38~46 (2005)
  7. Brzezinski A, "Melatonin in Humans", N Engl J Med, 336, pp.186~195 (1997)
  8. Chen HY, "Melatonin decreases neurovascular oxidative", nitrosative damage and protects against early increases in the blood–brain barrier permeability after transient focal cerebral ischemia in mice, 2006, pp.41, 175~182
  9. Choi JY, "The effects of the severity of periventricular leukomalacia on the neuropsychological outcomes of preterm children", J Child Neurol, 31, pp.603~612 (2016)
  10. Chung SY, "Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition", J Pineal Res, 34, pp.95~102 (2003)
  11. Claustrat B, "The basic physiology and pathophysiology of melatonin", Sleep Med Rev, 9, pp.11~24 (2005)
  12. Collaco JM, "Respiratory phenotypes for preterm infants, children, and adults: bronchopulmonary dysplasia and more", Ann Am Thorac Soc, 15, pp.530~538 (2018)
  13. Collins JJP, "Inflammation in fetal sheep from intraamniotic injection of Ureaplasma parvum", Am J Physiol Lung Cell Mol Physiol, 299, pp.L852~L860 (2010)
  14. Deacon S, "Acute phase-shifting effects of melatonin associated with suppression of core body temperature in humans", Neurosci Lett, 178, pp.32~34 (1994)
  15. Deng WG, "Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding", Blood, 108, pp.518~524 (2006)
  16. Domínguez Rubio AP, "Melatonin prevents experimental preterm labor and increases offspring survival", J Pineal Res, 56, pp.154~162 (2014)
  17. El Frargy M, "Use of melatonin as an adjuvant therapy in neonatal sepsis", J Neonatal Perinatal Med, 8, pp.227~232 (2015)
  18. Eloundou SN, "Placental malperfusion in response to intrauterine inflammation and its connection to fetal sequelae", PLoS One, 14, pp.e0214951~ (2019)
  19. Esmon CT, "The interactions between inflammation and coagulation", Br J Haematol, 131, pp.417~430 (2005)
  20. Folkerth RD, "Periventricular leukomalacia : overview and recent findings", Pediatr Dev Pathol, 9, pp.3~13 (2006)
  21. Gantert M, "Chorioamnionitis: a multiorgan disease of the fetus?", J Perinatol, 30, pp.S21~S30 (2010)
  22. Gavilanes AW, "Chorioamnionitis induced by intraamniotic lipopolysaccharide resulted in an intervaldependent increase in central nervous system injury in the fetal sheep", Am J Obstet Gynecol, 200, pp.437.e1~437.e8 (2009)
  23. Gitto E, "Effects of melatonin treatment in septic newborns", Pediatr Res, 50, pp.756~760 (2001)
  24. Gitto E, "Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin", J Pineal Res, 36, pp.250~255 (2004)
  25. Gitto E, "Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns : beneficial effects of melatonin", Am J Perinatol, 21, pp.209~216 (2004)
  26. Gitto E, "Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns:improvement with melatonin treatment", J Pineal Res, 39, pp.287~293 (2005)
  27. Goldenberg RL, "Epidemiology and causes of preterm birth", Lancet, 371, pp.75~84 (2008)
  28. Gomez-Lopez N, "Intra-amniotic administration of lipopolysaccharide induces spontaneous preterm labor and birth in the absence of a body temperature change", J Matern Fetal Neonatal Med, 31, pp.439~446 (2018)
  29. Graham HK, "Cerebral palsy", Nat Rev Dis Primers, 2, pp.15082~ (2016)
  30. Gravett MG, "An experimental model for intraamniotic infection and preterm labor in rhesus monkeys", Am J Obstet Gynecol, 171, pp.1660~1667 (1994)
  31. Hagberg H, "The role of inflammation in perinatal brain injury", Nat Rev Neurol, 11, pp.192~208 (2015)
  32. Higgins RD, "Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis : summary of a workshop", Obstet Gynecol, 127, pp.426~436 (2016)
  33. Hsu CN, "Perinatal use of melatonin for offspring health : focus on cardiovascular and neurological diseases", Int J Mol Sci, 20, pp.5681~ (2019)
  34. Husain AN, "Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia", Hum Pathol, 29, pp.710~717 (1998)
  35. Kallapur SG, "Vascular changes after intra-amniotic endotoxin in preterm lamb lungs", Am J Physiol Lung Cell Mol Physiol, 287, pp.L1178~L1185 (2004)
  36. Kallapur SG, "Fetal immune response to chorioamnionitis", Semin Reprod Med, 32, pp.56~67 (2014)
  37. Karasek M, "Melatonin, human aging, and age-related diseases", Exp Gerontol, 39, pp.1723~1729 (2004)
  38. Kim CJ, "Acute chorioamnionitis and funisitis : definition, pathologic features, and clinical significance", Am J Obstet Gynecol, 213, pp.S29~S52 (2015)
  39. Lal CV, "Ureaplasma infection-mediated release of matrix metalloproteinase-9 and PGP : a novel mechanism of preterm rupture of membranes and chorioamnionitis", Pediatr Res, 81, pp.75~79 (2017)
  40. Lanoix D, "Melatonin : the watchdog of villous trophoblast homeostasis against hypoxia", reoxygenation-induced oxidative stress and apoptosis, 2013, pp.381, 35~45
  41. Lee JY, "Melatonin for prevention of placental malperfusion and fetal compromise associated with intrauterine inflammation-induced oxidative stress in a mouse model", J Pineal Res, 67, pp.e12591~ (2019)
  42. Lee JY, "Melatonin for prevention of fetal lung injury associated with intrauterine inflammation and for lung maturation", J Pineal Res, 69, pp.e12687~ (2020)
  43. Lee JY, "Administration of melatonin for prevention of preterm birth and fetal brain injury associated with premature birth in a mouse model", Am J Reprod Immunol, 82, pp.e13151~ (2019)
  44. Lee MY, "Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats", J Pineal Res, 42, pp.297~309 (2007)
  45. Malpaux B, "Biology of mammalian photoperiodism and the critical role of the pineal gland and melatonin", J Biol Rhythms, 16, pp.336~347 (2001)
  46. Mauriz JL, "A review of the molecular aspects of melatonin's anti-inflammatory actions : recent insights and new perspectives", J Pineal Res, 54, pp.1~14 (2013)
  47. McAdams RM, "The role of cytokines and inflammatory cells in perinatal brain injury", Neurol Res Int, 2012, pp.561494~ (2012)
  48. McCarthy R, "Riding the rhythm of melatonin through pregnancy to deliver on time", Front Endocrinol(Lausanne), 10, pp.616~ (2019)
  49. Metzger RJ, "The branching programme of mouse lung development", Nature, 453, pp.745~750 (2008)
  50. Mourani PM, "Pulmonary vascular disease in bronchopulmonary dysplasia : pulmonary hypertension and beyond", Curr Opin Pediatr, 25, pp.329~337 (2013)
  51. Munshi UK, "Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia", Pediatr Pulmonol, 24, pp.331~336 (1997)
  52. Myatt L, "Oxidative stress in the placenta", Histochem Cell Biol, 122, pp.369~382 (2004)
  53. Nakamura Y, "Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy", J Pineal Res, 30, pp.29~33 (2001)
  54. Olegário JG, "Pulmonary innate immune response and melatonin receptors in the perinatal stress", Clin Dev Immunol, 2013, pp.340959~ (2013)
  55. Østensen M, "Nonsteroidal anti-inflammatory drugs during pregnancy", Scand J Rheumatol, 27, pp.128~132 (1998)
  56. Pan L, "Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia", World J Pediatr, 5, pp.216~221 (2009)
  57. Paredes SD, "Phytomelatonin : a review", J Exp Bot, 60, pp.57~69 (2008)
  58. Ray A, "Antibiotics prior to amniotomy for reducing infectious morbidity in mother and infant", Cochrane Database Syst Rev, (10), pp.CD010626~ (2014)
  59. Rodrigues Helmo F, "Melatonin treatment in fetal and neonatal diseases", Pathol Res Pract, 214, pp.1940~1951 (2018)
  60. Romero R, "Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome", J Nutr, 133, pp.1668S~1673S (2003)
  61. Romero R, "Human decidua : a source of cachectin-tumor necrosis factor", Eur J Obstet Gynecol Reprod Biol, 41, pp.123~127 (1991)
  62. Sagrillo-Fagundes L, "Melatonin in pregnancy : effects on brain development and CNS programming disorders", Curr Pharm Des, 22, pp.978~986 (2016)
  63. Sánchez A, "Evaluating the oxidative stress in inflammation : role of melatonin", Int J Mol Sci, 16, pp.16981~17004 (2015)
  64. Song J, "The protective effect of melatonin on neural stem cell against LPS-induced inflammation", Biomed Res Int, 2015, pp.854359~ (2015)
  65. Stavsky M, "Cerebral palsy—trends in epidemiology and recent development in prenatal mechanisms of disease, treatment, and prevention", Front Pediatr, 5, pp.21~ (2017)
  66. Stoll BJ, "Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network", Pediatrics, 126, pp.443~456 (2010)
  67. Strijbis EMM, "Cerebral palsy and the application of the International Criteria for Acute Intrapartum Hypoxia", Obstet Gynecol, 107, pp.1357~1365 (2006)
  68. Sun FY, "Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia", J Pineal Res, 33, pp.48~56 (2002)
  69. Tan DX, "One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species?", J Pineal Res, 42, pp.28~42 (2007)
  70. Thibeault DW, "Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease", Pediatrics, 106, pp.1452~1459 (2000)
  71. Tomás-Zapico C, "A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes", J Pineal Res, 39, pp.99~104 (2005)
  72. Tricoire H, "Melatonin enters the cerebrospinal fluid through the pineal recess", Endocrinology, 143, pp.84~90 (2002)
  73. Villamor-Martinez E, "Association of chorioamnionitis with bronchopulmonary dysplasia among preterm infants : a systematic review, meta-analysis, and metaregression", JAMA Netw Open, 2, pp.e1914611~ (2019)
  74. Volpe JJ, "Neurobiology of periventricular leukomalacia in the premature infant", Pediatr Res, 50, pp.553~562 (2001)
  75. Watanabe K, "Maternally administered melatonin protects against ischemia and reperfusion-induced oxidative mitochondrial damage in premature fetal rat brain", J Pineal Res, 37, pp.276~280 (2004)
  76. Welin AK, "Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion", Pediatr Res, 61, pp.153~158 (2007)
  77. Wenstrom KD, "Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery", Am J Obstet Gynecol, 178, pp.546~550 (1998)
  78. Wu YH, "Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: Colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone", J Comp Neurol, 499, pp.897~910 (2006)
  79. Wu YW, "Chorioamnionitis as a risk factor for cerebral palsy : a meta-analysis", JAMA, 284, pp.1417~1424 (2000)
  80. Yawno T, "Mechanisms of melatonin-induced protection in the brain of late gestation fetal sheep in response to hypoxia", Dev Neurosci, 34, pp.543~551 (2012)
  81. Yoon BH, "Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy", Am J Obstet Gynecol, 177, pp.19~26 (1997)
  82. Yoon BH, "Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits", Am J Obstet Gynecol, 177, pp.797~802 (1997)
  83. Yoon BH, "High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia", Am J Obstet Gynecol, 177, pp.406~411 (1997)

관련 논문AI추천

조기분만 시 조직학적 융모양막염 유무에 따른 혈청 C-반응성 단백질, 태반 내 interleukin-6, 지질과산화도 및 단백산화도강우대, 김석모, 김윤하, 김종운, 김철홍, 송태복, 윤대석, 이기호, 조문경, 조혜연대한산부인과학회 · Obstetrics & Gynecology Science2011 · 제54권 제1호신생쥐에서 유발시킨 저산소 허혈 뇌손상에 대한 melatonin과 저체온치료 병용요법의 효과김천수, 박재현, 이상락, 이성룡대한신생아학회 · Neonatal medicine2014 · 제21권 제2호Potency of Melatonin in Living Beings최돈찬한국발생생물학회 · 발생과 생식2013 · 제17권 제3호Chronic Placental Inflammation as a Risk Factor of Severe Retinopathy of Prematurity김기수, 김은나, 김종재, 김채영, 송우선, 이병섭, 이주용, 정의석, 황지혜, Ellen Ai-Rhan Kim대한병리학회 · Journal of Pathology and Translational Medicine2018 · 제52권 제5호Clinical Significance of Newborn Gastric Inflammatory MediatorsHye Sim Kang, Soon Sup Shim, Young Don Kim, Young-Hee Maeng대한신생아학회 · Neonatal medicine2016 · 제23권 제1호임신나이 28주 미만의 신생아에서 다양한 조직학적 융모양막염 기준에 따른 신생아기 유병률의 비교김규리, 김병일, 김윤주, 김이경, 김한석, 손세형, 손진아, 신승한, 이재명, 이주영, 이진아, 최가영, 최중환, 최창원대한신생아학회 · Neonatal medicine2013 · 제20권 제1호

이 간행물의 다른 논문 (5건)